SCHEMBL30097049

SCHEMBL30097049

CCCCOC(=O)NCc1cc2nc(Cl)ccc2cn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPKAPK2 P49137 1/20 0.42
SMN1; SMN2 Q16637 4/20 0.41
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
ALDH1A1 P00352 3/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C19 P33261 2/20 0.41
NFKB1 P19838 1/20 0.41
STAT1 P42224 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
HPGD P15428 3/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 3/20 0.40
L3MBTL1 Q9Y468 4/20 0.39
TGFBR1 P36897 2/20 0.39
FAAH O00519 1/20 0.39
BCHE P06276 1/20 0.38
LIPE Q05469 1/20 0.38
LMNA P02545 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30097042 0.83 TSHR (0.43) MAPKAPK2SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL29673310 0.80 KDM4A (0.42) MAPKAPK2L3MBTL1BCHEMAPK1
SCHEMBL23705506 0.80 KDM4A (0.42) MAPKAPK2L3MBTL1BCHEMAPK1
SCHEMBL29673308 0.80 KDM4A (0.42) MAPKAPK2L3MBTL1BCHEMAPK1
SCHEMBL30097018 0.80 ATM (0.44) MAPKAPK2SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL23705919 0.79 L3MBTL1 (0.36) SMN1; SMN2NPC1RAB9AHPGDL3MBTL1
SCHEMBL30103111 0.79 ALDH1A1 (0.36) MAPKAPK2SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL30097047 0.78 FAAH (0.44) MAPKAPK2SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL17017926 0.78 L3MBTL1 (0.46) MAPKAPK2SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL30689837 0.77 CNR1 (0.38) SMN1; SMN2NPC1RAB9AALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4096667-A1 COMPOUNDS AND USES THEREOF Foghorn Therapeutics Inc. (US) 2022-12-07 EP disclosed